Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


JPMA Urges Drug Makers To Establish Pandemic Guidelines Amid Flu Infections

This article was originally published in PharmAsia News

Executive Summary

Japan Pharmaceutical Manufacturers Association is urging member companies to establish flu pandemic guidelines. The drug makers' trade association found that out of 60 member companies that responded to a recent survey, 40 have established such guidelines, and JPMA urged quick action for the remaining companies. The recent domestic flu infections in Japan has prompted many drug companies to take measures such as reducing sales visits to hospitals. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts